Drugs / Extract of Ginkgo Biloba Leaves
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07220538 | Nov 2025 → Dec 2027 expected | cerebral artery occlusion, cognitive impairment with or without cerebellar ataxia | Dr. Willmar Schwabe GmbH & Co. KG | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Extract of Ginkgo Biloba Leaves | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07220538 ↗ |